Literature DB >> 12574515

Phenotype variation in two-locus mouse models of Hirschsprung disease: tissue-specific interaction between Ret and Ednrb.

Andrew S McCallion1, Erine Stames, Ronald A Conlon, Aravinda Chakravarti.   

Abstract

Clinical expression of Hirschsprung disease (HSCR) requires the interaction of multiple susceptibility genes. Molecular genetic analyses have revealed that interactions between mutations in the genes encoding the RET receptor tyrosine kinase and the endothelin receptor type B (EDNRB) are central to the genesis of HSCR. We have established two locus noncomplementation assays in mice, using allelic series at Ednrb in the context of Ret kinase-null heterozygotes, to understand the clinical presentation, incomplete penetrance, variation in length of aganglionic segment, and sex bias observed in human HSCR patients. Titration of Ednrb in the presence of half the genetic dose of Ret determines the presentation of an enteric phenotype in these strains, revealing or abrogating a sex bias in disease expression depending on the genotype at Ednrb. RET and EDNRB signaling pathways are also critical for the normal development of other tissues, including the kidneys and neural crest-derived melanocytes. Our data demonstrate that interaction between these genes is restricted to the enteric nervous system and does not affect renal, coat color, and retinal choroid development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574515      PMCID: PMC149918          DOI: 10.1073/pnas.0337540100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

Review 1.  EDNRB/EDN3 and Hirschsprung disease type II.

Authors:  A S McCallion; A Chakravarti
Journal:  Pigment Cell Res       Date:  2001-06

2.  Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts.

Authors:  D G Wilkinson; M A Nieto
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

3.  The molecular basis of dominance.

Authors:  H Kacser; J A Burns
Journal:  Genetics       Date:  1981 Mar-Apr       Impact factor: 4.562

4.  Mutations of the RET proto-oncogene in Hirschsprung's disease.

Authors:  P Edery; S Lyonnet; L M Mulligan; A Pelet; E Dow; L Abel; S Holder; C Nihoul-Fékété; B A Ponder; A Munnich
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

5.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease.

Authors:  G Romeo; P Ronchetto; Y Luo; V Barone; M Seri; I Ceccherini; B Pasini; R Bocciardi; M Lerone; H Kääriäinen
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

6.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret.

Authors:  A Schuchardt; V D'Agati; L Larsson-Blomberg; F Costantini; V Pachnis
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

7.  Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons.

Authors:  A G Baynash; K Hosoda; A Giaid; J A Richardson; N Emoto; R E Hammer; M Yanagisawa
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

8.  A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease.

Authors:  E G Puffenberger; K Hosoda; S S Washington; K Nakao; D deWit; M Yanagisawa; A Chakravart
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

9.  Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice.

Authors:  K Hosoda; R E Hammer; J A Richardson; A G Baynash; J C Cheung; A Giaid; M Yanagisawa
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  [Mutations of RET proto-oncogene in Hirschsprung disease].

Authors:  S Lyonnet; P Edery; L M Mulligan; A Pelet; E Dow; L Abel; S Holder; C Nihoul-Fékéte; B A Ponder; A Munnich
Journal:  C R Acad Sci III       Date:  1994-04
View more
  47 in total

1.  Clinical relationship between EDN-3 gene, EDNRB gene and Hirschsprung's disease.

Authors:  Xiang-Long Duan; Xian-Sheng Zhang; Guo-Wei Li
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 2.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

3.  Genetic background impacts developmental potential of enteric neural crest-derived progenitors in the Sox10Dom model of Hirschsprung disease.

Authors:  Lauren C Walters; V Ashley Cantrell; Kevin P Weller; Jack T Mosher; E Michelle Southard-Smith
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

4.  Hirschsprung's disease, Down syndrome, and missing heritability: too much collagen slows migration.

Authors:  Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

Review 5.  Enteric nervous system development: A crest cell's journey from neural tube to colon.

Authors:  Nandor Nagy; Allan M Goldstein
Journal:  Semin Cell Dev Biol       Date:  2017-01-10       Impact factor: 7.727

Review 6.  Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities.

Authors:  Michael D Gershon; Elyanne M Ratcliffe
Journal:  Semin Pediatr Surg       Date:  2004-11       Impact factor: 2.754

Review 7.  Transplanting the enteric nervous system: a step closer to treatment for aganglionosis.

Authors:  Michael D Gershon
Journal:  Gut       Date:  2007-04       Impact factor: 23.059

8.  [Genetic bases of Hirschsprung's disease].

Authors:  E Passarge; E Bruder
Journal:  Pathologe       Date:  2007-03       Impact factor: 1.011

Review 9.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 10.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.